Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Advances in Modifying BMPR2 Signaling in PAH

23 Dec 2020

Abstract excerpt

Pulmonary Arterial Hypertension (PAH) is a disease of the pulmonary arteries, that is characterized by progressive narrowing of the pulmonary arterial lumen and increased pulmonary vascular resistance, ultimately leading to right ventricular dysfunction, heart failure and premature death. Current treatments mainly target pulmonary vasodilation and leave the progressive vascular remodeling unchecked resulting in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pulmonary Hypertension Research and Treatments

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 33374819
DOI: 10.3390/genes12010008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Advances in Modifying BMPR2 Signaling in PAHPMID 33374819Read ↗

Significance of BMPR2 mutations in pulmonary arterial hypertension.Semantic proximity Read ↗

BMP type II receptor as a therapeutic target in pulmonary arterial hypertensionSemantic proximity Read ↗

Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Semantic proximity Read ↗

Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.Semantic proximity Read ↗

Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.Semantic proximity Read ↗

A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertensionSemantic proximity Read ↗

Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension.Semantic proximity Read ↗

Molecular pathogenesis of pulmonary arterial hypertension.Semantic proximity Read ↗

BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)Semantic proximity Read ↗

Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.Semantic proximity Read ↗

Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.Semantic proximity Read ↗

An emerging class of new therapeutics targeting TGF , Activin, and BMP ligands in pulmonary arterial hypertensionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.